Takeda CEO Admits Missteps In Expanding Global Generics Markets
This article was originally published in PharmAsia News
Executive Summary
Takeda Pharmaceutical CEO Yasuchika Hasegawa acknowledged in an interview his company made some serious errors recently in its struggle to morph from a drug innovator to one globally competitive in generics.